PURE Bioscience, Inc.

PURE · OTC
Analyze with AI
10/31/2025
7/31/2025
4/30/2025
1/31/2025
Assets
Cash & Equivalents$509$334$540$202
Short-Term Investments$0$0$0$0
Receivables$389$474$287$180
Inventory$237$141$131$75
Other Curr. Assets$41$98$88$105
Total Curr. Assets$1,176$1,047$1,046$562
Property Plant & Equip (Net)$10$11$11$12
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$10$11$11$12
Other Assets$0$0$0$0
Total Assets$1,186$1,058$1,057$574
Liabilities
Payables$879$784$799$700
Short-Term Debt$2,104$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$176$154$173$166
Total Curr. Liab.$3,159$938$972$866
LT Debt$3,573$5,236$4,899$3,975
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,573$5,236$4,899$3,975
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$6,732$6,174$5,871$4,841
Equity
Pref Stock$0$0$0$0
Common Stock$1,119$1,119$1,119$1,119
Retained Earnings-$139,458-$138,994-$138,662-$138,082
AOCI$0$0$0$0
Other Equity$132,793$132,759$132,729$133,562
Total Equity-$5,546-$5,116-$4,814-$3,401
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,186$1,058$1,057$574
Net Debt$5,168$4,902$4,359$3,773